|Files in This Item:|
There are no files associated with this item.
|Title: ||Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.|
|Affiliation: ||Department of Respiratory Medicine, National Children's Hospital, Tallaght, Dublin 24. Peter.Greally@amnch.ie|
|Citation: ||Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. 2009, 102 (1):29 Ir Med J|
|Journal: ||Irish medical journal|
|Issue Date: ||Jan-2009 |
|PubMed ID: ||19284017|
|Abstract: ||Allergic bronchopulmonary aspergillosis (ABPA) can cause a significant clinical deterioration in patients with cystic fibrosis. There is very little research in the current literature with regard to alternatives for treatment, apart from long courses of steroids. We conducted a retrospective review of all our patients with ABPA treated with the antifungal voriconazole and found there was a significant drop in IgE levels post treatment as well as a decrease in steroid dosing. The improvement in FEV was not statistically significant; however there was a very wide variation in pre-treatment levels.|
Aspergillosis, Allergic Bronchopulmonary
Forced Expiratory Volume
|Appears in Collections: ||Adelaide Meath Hospital Tallaght|
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.